查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1911599

體外膜氧合（ECMO）設備市場規模、佔有率和成長分析（按組件、模式、患者年齡層、應用、最終用戶和地區分類）—2026-2033年產業預測

Extracorporeal Membrane Oxygenation Machine Market Size, Share, and Growth Analysis, By Component, By Modality (Veno-Venous, Veno-Arterial ), By Patient Age Group, By Application, By End-User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 197 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球體外膜氧合（ECMO）設備市場規模預計在 2024 年達到 3.2822 億美元，從 2025 年的 3.4594 億美元成長到 2033 年的 5.269 億美元，在預測期（2026-2033 年）內複合成長率為 5.4%。

由於體外膜氧合（ECMO）在常規治療方法無效時對治療嚴重心臟衰竭衰竭發揮至關重要的作用，全球ECMO設備市場正經歷溫和成長。推動需求成長的關鍵因素包括重症監護設施的進步、心肺疾病發病率的上升以及ECMO在臨床上的接受度不斷提高。 ECMO技術的創新有望提升便攜性，採用生物相容性材料，並整合監測系統以應對緊急情況和轉運場景。專業ECMO中心的建立和多學科培訓計畫的實施正在推動ECMO的普及。然而，挑戰依然存在，包括高成本、訓練有素的專業人員短缺、複雜的管理要求限制了其在專業醫院的使用，以及影響市場進入的報銷和監管壁壘。

全球體外膜氧合（ECMO）設備市場促進因素

全球體外膜氧合（ECMO）設備市場的主要促進因素之一是呼吸系統和心臟疾病的日益普遍，這些疾病需要先進的醫療干預。隨著醫療機構不斷尋求針對嚴重肺功能障礙和心臟衰竭患者的有效解決方案，ECMO設備因其在重症監護環境中提供生命維持的能力而日益重要。此外，ECMO技術的進步，例如攜帶式型號和生物相容性的提高，以及人們對人工器官系統的認知不斷加深，都透過改善患者預後和提供更好的治療方案，顯著促進了市場的擴張。

限制全球體外膜氧合（ECMO）設備市場的因素

全球體外膜氧合（ECMO）設備市場的主要限制因素是購買和維護這些設備的高昂成本。 ECMO設備所需的大量投資，以及醫護人員培訓和配套基礎設施的相關費用，都可能成為許多醫療機構，特別是新興經濟體醫療機構的障礙。此外，報銷難題和監管障礙也會進一步限制ECMO技術的應用，並阻礙其在重症監護環境中的普及和使用。這種經濟負擔會限制患者享受ECMO救命治療的機會，進而影響整個市場的成長。

體外膜氧合（ECMO）設備市場的全球趨勢

全球體外膜氧合（ECMO）設備市場正呈現出高度便攜、易於操作的系統發展的顯著趨勢。製造商正致力於開發緊湊、輕巧、可移動的ECMO設備，使其能夠在傳統加護病房之外有效應用。這項創新使得患者能夠在小規模的醫療機構中轉運和接受治療，這對於農村和資源匱乏地區尤其重要。這些可攜式系統簡化的設置流程提高了ECMO治療的可及性，最終擴大了患者照護的覆蓋範圍，並滿足了不同醫療環境中的迫切需求。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2025）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 技術評估
  • 監管環境
  • 原料分析

全球體外膜氧合（ECMO）設備市場規模（依組件分類）及複合年成長率（2026-2033）

  • 泵浦
  • 氧合設備
  • 控制器
  • 套管和導管套裝
  • 配件和耗材

全球體外膜氧合（ECMO）設備市場規模（按模式和複合年成長率分類）（2026-2033 年）

  • 靜脈-靜脈（VV）
  • 靜脈-動脈（VA）
  • 動靜脈（AV）

全球體外膜氧合（ECMO）設備市場規模（依病患年齡層分類）及複合年成長率（2026-2033 年）

  • 新生
  • 兒童
  • 成人

全球體外膜氧合（ECMO）設備市場規模：按應用和複合年成長率分類（2026-2033 年）

  • 呼吸系統疾病
  • 心臟病
  • 體外心肺復甦術（ECPR）

全球體外膜氧合（ECMO）設備市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

  • 醫院（加護病房/心臟監護室）
  • 專科診所
  • 緊急醫療服務

全球體外膜氧合（ECMO）設備市場規模及複合年成長率（2026-2033）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2025 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2025 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Medtronic plc
  • Getinge AB
  • LivaNova PLC
  • Terumo Cardiovascular Corporation
  • Nipro Corporation
  • Eurosets Srl
  • Maquet Holding（Getinge Group）
  • CytoSorbents Corporation
  • Medos Medizintechnik AG
  • Microport Scientific Corporation
  • Philips Healthcare（ECLS division）
  • Edwards Lifesciences Corporation
  • Xenios AG
  • Saranas Inc.
  • Oxygen Plus Medical Systems
  • Hemovent GmbH
  • Abiomed Inc.
  • Boston Scientific Corporation
  • Smiths Medical（ICU Life Support Division）
  • Baxter International Inc.

結論與建議

簡介目錄
Product Code: SQMIG35A3132

Global Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 328.22 Million in 2024 and is poised to grow from USD 345.94 Million in 2025 to USD 526.9 Million by 2033, growing at a CAGR of 5.4% during the forecast period (2026-2033).

The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing gradual growth, driven by its essential role in managing severe cardiac and respiratory failure when conventional treatments fail. Key factors fueling demand include advancements in critical care facilities, rising incidences of cardiopulmonary diseases, and greater clinical acceptance of ECMO. Innovations in ECMO technology are expected to enhance portability, incorporate biocompatible materials, and feature integrated monitoring systems, catering to emergency and transport scenarios. The establishment of specialized ECMO centers and multidisciplinary training programs is bolstering adoption rates. However, challenges remain, such as high equipment costs, a shortage of trained professionals, and complex management requirements that confine usage to specialized hospitals, along with reimbursement and regulatory hurdles impacting market access.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Extracorporeal Membrane Oxygenation Machine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Extracorporeal Membrane Oxygenation Machine Market Segments Analysis

Global Extracorporeal Membrane Oxygenation Machine Market is segmented by Component, Modality, Patient Age Group, Application, End-User and region. Based on Component, the market is segmented into Pumps, Oxygenators, Controllers, Cannula & Tubing Sets and Accessories & Consumables. Based on Modality, the market is segmented into Veno-Venous (VV), Veno-Arterial (VA) and Arterio-Venous (AV). Based on Patient Age Group, the market is segmented into Neonates, Pediatrics and Adults. Based on Application, the market is segmented into Respiratory Disorders, Cardiac Conditions and Extracorporeal Cardiopulmonary Resuscitation (ECPR). Based on End-User, the market is segmented into Hospitals (ICU / Cardiac Care Units), Specialty Clinics and Emergency Medical Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Extracorporeal Membrane Oxygenation Machine Market

One of the key market drivers for the global extracorporeal membrane oxygenation (ECMO) machine market is the growing prevalence of respiratory and cardiac diseases, which demand advanced medical interventions. As healthcare providers increasingly seek effective solutions for patients experiencing severe pulmonary or cardiac distress, ECMO machines have gained prominence for their capability to provide life-sustaining support in critical care settings. Additionally, advancements in ECMO technology, such as portable models and improved biocompatibility, alongside the rising awareness of artificial organ systems, significantly contribute to the market's expansion by enhancing patient outcomes and facilitating better treatment options.

Restraints in the Global Extracorporeal Membrane Oxygenation Machine Market

A significant market restraint for the global extracorporeal membrane oxygenation (ECMO) machine market is the high cost associated with the acquisition and maintenance of these devices. The substantial investment required for ECMO machines, along with the expenses related to necessary training for medical personnel and supporting infrastructure, can be prohibitive for many healthcare facilities, particularly in emerging economies. Additionally, reimbursement challenges and regulatory hurdles can further limit the adoption of ECMO technology, hindering its availability and utilization in critical care settings. This financial burden may restrict access to the life-saving benefits of ECMO for patients, impacting overall market growth.

Market Trends of the Global Extracorporeal Membrane Oxygenation Machine Market

The Global Extracorporeal Membrane Oxygenation (ECMO) Machine market is experiencing a significant trend towards the development of portable and user-friendly systems. Manufacturers are focusing on creating compact, lightweight, and mobile ECMO devices that can be effectively utilized beyond conventional intensive care units. This innovation facilitates the transport and treatment of patients in smaller healthcare facilities, particularly beneficial for rural and resource-limited areas. The streamlined setup process of these portable systems enhances accessibility to ECMO therapy, ultimately broadening the scope of patient care and addressing critical needs in diverse healthcare environments.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape
  • Raw Material Analysis

Global Extracorporeal Membrane Oxygenation Machine Market Size by Component & CAGR (2026-2033)

  • Market Overview
  • Pumps
  • Oxygenators
  • Controllers
  • Cannula & Tubing Sets
  • Accessories & Consumables

Global Extracorporeal Membrane Oxygenation Machine Market Size by Modality & CAGR (2026-2033)

  • Market Overview
  • Veno-Venous (VV)
  • Veno-Arterial (VA)
  • Arterio-Venous (AV)

Global Extracorporeal Membrane Oxygenation Machine Market Size by Patient Age Group & CAGR (2026-2033)

  • Market Overview
  • Neonates
  • Pediatrics
  • Adults

Global Extracorporeal Membrane Oxygenation Machine Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Respiratory Disorders
  • Cardiac Conditions
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Global Extracorporeal Membrane Oxygenation Machine Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Hospitals (ICU / Cardiac Care Units)
  • Specialty Clinics
  • Emergency Medical Services

Global Extracorporeal Membrane Oxygenation Machine Market Size & CAGR (2026-2033)

  • North America (Component, Modality, Patient Age Group, Application, End-User)
    • US
    • Canada
  • Europe (Component, Modality, Patient Age Group, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Component, Modality, Patient Age Group, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Component, Modality, Patient Age Group, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Component, Modality, Patient Age Group, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Cardiovascular Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurosets S.r.l.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Maquet Holding (Getinge Group)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CytoSorbents Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medos Medizintechnik AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microport Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare (ECLS division)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xenios AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Saranas Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxygen Plus Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hemovent GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abiomed Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (ICU Life Support Division)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations